ELLEN RITCH: Open Payments
NPI 1700292281 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,660 in 144 payments from 21 companies in 2025. Trend: 2023 $1,466 · 2024 $2,576 · 2025 $2,660
Food & beverage: $2,660
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $370 |
| Alkermes, Inc. | 20 | $359 |
| Vanda Pharmaceuticals Inc. | 11 | $264 |
| Axsome Therapeutics, Inc. | 9 | $242 |
| ABBVIE INC. | 23 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $185 |
| E.R. Squibb & Sons, L.L.C. | 5 | $179 |
| Tris Pharma Inc | 15 | $157 |
| Biogen, Inc. | 1 | $105 |
Products named: REXULTI, ARISTADA, FANAPT, Auvelity, VRAYLAR, CAPLYTA, TRINTELLIX, COBENFY.
Industry payments across LA — which companies pay providers there.
